Despite being hit hardest by COVID-19, a substantial number of Black Americans continue to express skepticism about the COVID-19 vaccine. As a result, a new vaccine education tool kit aims to address their concerns and open up a dialogue within the Black community, according to a recent press release from the American Lung Association (ALA).… Read More: Tool Kit Supports Talk About COVID-19 Vaccines in Black Communities »
Dolutegravir or darunavir/ritonavir are equally effective in second-line treatment, even in the presence of high-level resistance to NRTIs included in the regimen, a large randomised study carried out in three African countries has found. Furthermore, tenofovir and lamivudine can be recycled in second-line treatment even in people with high-level resistance to the drugs, without undermining… Read More: African study confirms dolutegravir for second-line treatment and supports recycling… »
By Amy Norton HealthDay Reporter FRIDAY, Jan. 31, 2020 (HealthDay News) — The rate of colon cancer among Americans spikes sharply between the ages of 49 and 50, a new study finds — supporting the case for earlier screening for the disease. Researchers say the uptick between those two ages does not reflect an actual… Read More: New Study Supports Lowering Age of First Colonoscopy »
The standard unique Health Plan Identifier and Other Entity Identifier no longer serve the purposes for which they were adopted. That’s the message the American Hospital Association delivered on Tuesday in a letter to the Centers for Medicare and Medicaid Services in response to a proposed CMS rule to rescind the adoption of the HPID… Read More: AHA supports rescinding adoption of HPID, OEID »